NATAMYCIN

NATAMYCIN was reported 410 times

NATAMYCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PYTHIUM INSIDIOSUM INFECTION 2 0.2000
1 PERSISTENT GENITAL AROUSAL DISORDER 40 0.1724
2 SLEEP DISORDER THERAPY 34 0.1717
3 APPENDICOLITH 58 0.1499
4 EXSEROHILUM INFECTION 1 0.1250
5 ANALGESIC THERAPY 34 0.1059
6 INSTILLATION SITE BRUISE 1 0.1000
7 DRUG THERAPY 33 0.0973
8 ANTACID THERAPY 12 0.0923
9 OCULAR SURFACE SQUAMOUS NEOPLASIA 2 0.0800
10 BACTEROIDES INFECTION 19 0.0728
11 ACANTHAMOEBA KERATITIS 2 0.0541
12 UVEAL PROLAPSE 1 0.0455
13 MALIGNANT MELANOMA STAGE 0 9 0.0431
14 ANTICOAGULANT THERAPY 12 0.0423
15 NECROTISING SCLERITIS 6 0.0414
16 FEMALE REPRODUCTIVE TRACT DISORDER 9 0.0413
17 SEXUAL LIFE IMPAIRMENT 2 0.0408
18 CONGENITAL HIATUS HERNIA 9 0.0395
19 BLOOD SMEAR TEST ABNORMAL 3 0.0375
20 KERATITIS FUNGAL 7 0.0337
21 INFECTIVE KERATITIS 2 0.0282
22 INFECTIOUS CRYSTALLINE KERATOPATHY 1 0.0270
23 CORNEAL PERFORATION 15 0.0238
24 TEAR DISCOLOURATION 1 0.0222
25 HYPERPHOSPHATAEMIA 43 0.0200
26 BLOOD PHOSPHORUS INCREASED 52 0.0190
27 NEUROTROPHIC KERATOPATHY 1 0.0185
28 EYE INFECTION FUNGAL 7 0.0181
29 RADICULITIS LUMBOSACRAL 2 0.0180
30 CORNEAL INFILTRATES 5 0.0159
31 PERINEAL PAIN 9 0.0126
32 TOTAL LUNG CAPACITY DECREASED 20 0.0125
33 FOREIGN BODY IN EYE 12 0.0125
34 CORNEAL THINNING 3 0.0117
35 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 10 0.0108
36 SPOROTRICHOSIS 1 0.0101
37 DISTURBANCE IN SEXUAL AROUSAL 9 0.0098
38 BLOOD URIC ACID INCREASED 52 0.0090
39 IRON DEFICIENCY 40 0.0089
40 PERSISTENT CORNEAL EPITHELIAL DEFECT 1 0.0085
41 HYPOPYON 7 0.0085
42 CENTRAL VENOUS PRESSURE INCREASED 1 0.0082
43 LUNG OPACITY 21 0.0080
44 IRIDOCELE 1 0.0077
45 SUPERFICIAL INJURY OF EYE 8 0.0073
46 PERICARDIAL FIBROSIS 1 0.0072
47 LEUKAEMIC INFILTRATION 1 0.0071
48 OCULAR SURFACE DISEASE 2 0.0071
49 GENITAL PARAESTHESIA 2 0.0069
50 HYPOPHOSPHATAEMIA 51 0.0069
51 AORTIC STENOSIS 24 0.0069
52 MYASTHENIA GRAVIS 55 0.0068
53 APPENDICITIS 58 0.0062
54 KERATITIS BACTERIAL 1 0.0061
55 GENITAL PAIN 9 0.0061
56 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 27 0.0053
57 CONJUNCTIVAL DISORDER 2 0.0052
58 VENTRICULAR FIBRILLATION 58 0.0052
59 CORNEAL EPITHELIUM DEFECT 3 0.0052
60 ULCERATIVE KERATITIS 14 0.0051
61 EYE EXCISION 1 0.0049
62 DYSBACTERIOSIS 1 0.0047
63 OCULAR TOXICITY 5 0.0045
64 FUSARIUM INFECTION 3 0.0043
65 PRODUCT CONTAMINATION MICROBIAL 5 0.0042
66 CORNEAL NEOVASCULARISATION 1 0.0040
67 FOREIGN BODY SENSATION IN EYES 24 0.0038
68 CARDIOGENIC SHOCK 54 0.0038
69 SCLERAL DISORDER 1 0.0037
70 HYPERTENSIVE URGENCY 2 0.0036
71 CHEMICAL BURNS OF EYE 1 0.0036
72 EYE INFECTION STAPHYLOCOCCAL 1 0.0035
73 ANTERIOR CHAMBER INFLAMMATION 2 0.0034
74 EYE ABSCESS 1 0.0033
75 DYSAESTHESIA 10 0.0033
76 TROPONIN INCREASED 24 0.0032
77 RIGHT VENTRICULAR ENLARGEMENT 1 0.0031
78 SOFT TISSUE INFLAMMATION 1 0.0030
79 GRAFT INFECTION 1 0.0029
80 CORNEAL OPACITY 4 0.0029
81 POSTERIOR CAPSULE OPACIFICATION 1 0.0029
82 MYCOBACTERIUM CHELONAE INFECTION 2 0.0027
83 BACTERIAL INFECTION 50 0.0027
84 CORNEAL TRANSPLANT 2 0.0026
85 BLOOD CALCIUM INCREASED 22 0.0025
86 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 42 0.0024
87 STAPHYLOCOCCAL SKIN INFECTION 3 0.0024
88 NEURALGIA 55 0.0023
89 PRODUCT RESIDUE PRESENT 12 0.0022
90 PLEURITIC PAIN 6 0.0022
91 KERATIC PRECIPITATES 1 0.0021
92 THERAPY RESPONDER 1 0.0020
93 COMPLICATIONS OF TRANSPLANT SURGERY 1 0.0020
94 KERATITIS 6 0.0020
95 ASCITES 58 0.0020
96 MULTIPLE ORGAN DYSFUNCTION SYNDROME 55 0.0019
97 PRODUCT DEPOSIT 3 0.0019
98 CHOROIDAL DETACHMENT 1 0.0018
99 SUSPECTED PRODUCT TAMPERING 1 0.0018
100 RESPIRATORY SYMPTOM 5 0.0018
101 HYPERLIPIDAEMIA 21 0.0018
102 BENIGN PROSTATIC HYPERPLASIA 9 0.0017
103 ULCER 27 0.0017
104 BLOOD TEST ABNORMAL 23 0.0016
105 PRODUCT PHYSICAL CONSISTENCY ISSUE 9 0.0016
106 ENDOPHTHALMITIS 9 0.0015
107 MEDICATION RESIDUE PRESENT 7 0.0015
108 ANTERIOR CHAMBER CELL 1 0.0014
109 GOUT 25 0.0014
110 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
111 END STAGE RENAL DISEASE 25 0.0014
112 CORNEAL DISORDER 3 0.0014
113 EYE INJURY 4 0.0013
114 IRON DEFICIENCY ANAEMIA 12 0.0013
115 NEURITIS 2 0.0013
116 SUPERIOR SAGITTAL SINUS THROMBOSIS 1 0.0013
117 LIQUID PRODUCT PHYSICAL ISSUE 9 0.0012
118 FEAR OF FALLING 1 0.0012
119 SEPTIC EMBOLUS 1 0.0012
120 VITREOUS OPACITIES 1 0.0012
121 FOOD INTERACTION 2 0.0011
122 BLOOD CHOLESTEROL INCREASED 51 0.0011
123 OCULAR DISCOMFORT 12 0.0011
124 HYPONATRAEMIA 58 0.0010
125 BREATH SOUNDS ABNORMAL 5 0.0010
126 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 52 0.0010
127 ASPIRATION 10 0.0009
128 CARDIAC HYPERTROPHY 1 0.0009
129 RALES 5 0.0009
130 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
131 DYSPLASIA 1 0.0008
132 EYE DISCHARGE 8 0.0008
133 SEXUAL DYSFUNCTION 9 0.0008
134 ASPERGILLOSIS 1 0.0008
135 SLEEP DISORDER 53 0.0008
136 BRONCHIECTASIS 5 0.0007
137 DIABETES MELLITUS 56 0.0007
138 CORNEAL ABRASION 1 0.0007
139 EYE PAIN 41 0.0007
140 DRY MOUTH 57 0.0007
141 MICTURITION URGENCY 8 0.0007
142 CEREBELLAR HAEMORRHAGE 1 0.0007
143 THROMBOSIS 55 0.0007
144 IMPETIGO 1 0.0007
145 PATHOGEN RESISTANCE 6 0.0007
146 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
147 SCLERITIS 1 0.0006
148 LIVER FUNCTION TEST INCREASED 13 0.0006
149 INTENTIONAL PRODUCT MISUSE 53 0.0006
150 RETINAL THICKENING 1 0.0006
151 SWELLING 56 0.0006
152 POTENTIATING DRUG INTERACTION 2 0.0006
153 ABDOMINAL DISTENSION 62 0.0006
154 PSEUDOMONAS INFECTION 5 0.0006
155 PULMONARY EMBOLISM 51 0.0005
156 DRUG INTOLERANCE 51 0.0005
157 LOWER RESPIRATORY TRACT INFECTION 24 0.0005
158 SPUTUM DISCOLOURED 5 0.0005
159 EYE INFLAMMATION 5 0.0005
160 HYPERCHOLESTEROLAEMIA 5 0.0005
161 SEPSIS 55 0.0005
162 GENERAL PHYSICAL HEALTH DETERIORATION 57 0.0005
163 EYELID PAIN 1 0.0005
164 FULL BLOOD COUNT ABNORMAL 5 0.0005
165 ABNORMAL SENSATION IN EYE 2 0.0005
166 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
167 CORNEAL OEDEMA 1 0.0004
168 SUSPECTED OFF LABEL USE 2 0.0004
169 OCULAR HYPERAEMIA 21 0.0004
170 EYE IRRITATION 25 0.0004
171 VENOOCCLUSIVE DISEASE 1 0.0004
172 BLOOD CREATININE INCREASED 26 0.0004
173 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
174 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
175 PRODUCT COLOUR ISSUE 2 0.0004
176 RETINAL DISORDER 1 0.0004
177 PLEURAL EFFUSION 23 0.0004
178 JOINT INJURY 8 0.0004
179 PRODUCT DELIVERY MECHANISM ISSUE 2 0.0004
180 ASTHENOPIA 2 0.0004
181 TRANSAMINASES INCREASED 8 0.0004
182 EYE INFECTION 4 0.0004
183 EYELID MARGIN CRUSTING 1 0.0003
184 PULMONARY MASS 5 0.0003
185 CONDITION AGGRAVATED 100 0.0003
186 SQUAMOUS CELL CARCINOMA 3 0.0003
187 SOMNOLENCE 64 0.0003
188 VAGINAL DISCHARGE 3 0.0003
189 HAEMOPTYSIS 8 0.0003
190 MUSCULOSKELETAL STIFFNESS 25 0.0003
191 THROMBOPHLEBITIS 1 0.0003
192 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
193 CONJUNCTIVAL HYPERAEMIA 1 0.0003
194 RENAL TRANSPLANT 1 0.0003
195 ANAEMIA 52 0.0003
196 LACRIMATION INCREASED 8 0.0003
197 CORONARY ARTERY DISEASE 8 0.0003
198 PROCEDURAL COMPLICATION 2 0.0003
199 PULMONARY FIBROSIS 5 0.0003
200 CONSTIPATION 56 0.0003
201 ABDOMINAL PAIN 59 0.0003
202 PNEUMONIA FUNGAL 1 0.0003
203 BLOOD DISORDER 2 0.0002
204 TRIGEMINAL NEURALGIA 1 0.0002
205 GENERALISED OEDEMA 3 0.0002
206 PRODUCT DISPENSING ISSUE 1 0.0002
207 TONGUE DISCOLOURATION 1 0.0002
208 FACIAL PAIN 2 0.0002
209 CONJUNCTIVITIS 4 0.0002
210 OEDEMA PERIPHERAL 26 0.0002
211 PHOTOPHOBIA 4 0.0002
212 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
213 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
214 TREATMENT FAILURE 17 0.0002
215 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
216 CARDIOVASCULAR DISORDER 5 0.0002
217 EYELID PTOSIS 2 0.0002
218 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
219 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
220 NONSPECIFIC REACTION 1 0.0002
221 SKIN TOXICITY 1 0.0002
222 DERMATITIS CONTACT 2 0.0002
223 CATARACT OPERATION 1 0.0002
224 FOETAL GROWTH RESTRICTION 1 0.0002
225 SWELLING OF EYELID 1 0.0002
226 POOR QUALITY DRUG ADMINISTERED 1 0.0002
227 ASPERGILLUS INFECTION 1 0.0002
228 ADVERSE REACTION 2 0.0002
229 PRODUCT PHYSICAL ISSUE 3 0.0001
230 HYPERTENSION 31 0.0001
231 RIGHT VENTRICULAR FAILURE 1 0.0001
232 BURNING SENSATION 10 0.0001
233 PULMONARY TOXICITY 1 0.0001
234 RETINAL HAEMORRHAGE 1 0.0001
235 GRAFT VERSUS HOST DISEASE 1 0.0001
236 LIVER DISORDER 6 0.0001
237 HEPATOTOXICITY 3 0.0001
238 PRODUCT USE IN UNAPPROVED INDICATION 33 0.0001
239 THYROID DISORDER 2 0.0001
240 LOW BIRTH WEIGHT BABY 1 0.0001
241 GINGIVAL PAIN 1 0.0001
242 VOMITING 59 0.0001
243 SENSORY DISTURBANCE 2 0.0001
244 FRUSTRATION TOLERANCE DECREASED 1 0.0001
245 DRUG LEVEL INCREASED 2 0.0001
246 VISUAL ACUITY REDUCED 4 0.0001
247 LEUKOPENIA 6 0.0001
248 EYE PRURITUS 4 0.0001
249 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
250 HYPOXIA 4 0.0001
251 PURPURA 1 0.0001
252 FEAR 3 0.0001
253 RETINAL DETACHMENT 1 0.0001
254 DRUG-INDUCED LIVER INJURY 3 0.0001
255 INCONTINENCE 1 0.0001
256 SUDDEN DEATH 1 0.0001
257 HYPOTHYROIDISM 3 0.0001
258 DYSPNOEA 53 0.0001
259 OFF LABEL USE 81 0.0001
260 BLOOD CALCIUM DECREASED 1 0.0001
261 DRUG INEFFECTIVE 117 0.0001
262 ASTHMA 10 0.0001
263 PRODUCT QUALITY ISSUE 12 0.0001
264 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
265 GASTRIC HAEMORRHAGE 1 0.0001
266 DRUG INTERACTION 13 0.0001
267 LUNG DISORDER 4 0.0001
268 DYSURIA 3 0.0001
269 EYE SWELLING 3 0.0001
270 BRAIN OEDEMA 1 0.0001
271 INTRAOCULAR PRESSURE INCREASED 1 0.0001
272 GASTROINTESTINAL DISORDER 7 0.0001
273 IMMUNE SYSTEM DISORDER 1 0.0001
274 PRODUCT DOSE OMISSION ISSUE 22 0.0001
275 QUALITY OF LIFE DECREASED 1 0.0001
276 DISTURBANCE IN ATTENTION 4 0.0001
277 PNEUMONIA 24 0.0001
278 NAUSEA 58 0.0001
279 BLINDNESS UNILATERAL 1 0.0001
280 ANOSMIA 1 0.0001
281 HYPERTHYROIDISM 1 0.0001
282 PRODUCT STORAGE ERROR 6 0.0001
283 HAEMORRHAGE INTRACRANIAL 1 0.0001
284 THERAPY NON-RESPONDER 3 0.0001
285 PREMATURE BABY 2 0.0001
286 ECONOMIC PROBLEM 1 0.0001
287 DRUG DISPENSING ERROR 1 0.0001
288 VISUAL IMPAIRMENT 8 0.0001
289 THERAPY PARTIAL RESPONDER 1 0.0001
290 PRODUCT USE ISSUE 12 0.0001
291 ANXIETY 18 0.0001
292 PREMATURE DELIVERY 1 0.0001
293 EYE DISORDER 2 0.0001
294 FUNGAL INFECTION 2 0.0001
295 PERICARDITIS 1 0.0001
296 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
297 DISEASE PROGRESSION 7 0.0001
298 VISION BLURRED 8 0.0001
299 DEVICE USE ISSUE 1 0.0001
300 NEUROTOXICITY 1 0.0001
301 DERMATITIS ATOPIC 3 0.0001
302 THIRST 1 0.0001
303 MEDICATION ERROR 3 0.0001
304 GLAUCOMA 1 0.0001
305 WHEEZING 3 0.0001
306 PRODUCT ADMINISTRATION ERROR 1 0.0000
307 BONE MARROW FAILURE 1 0.0000
308 MELAENA 1 0.0000
309 HEPATIC ENZYME INCREASED 3 0.0000
310 PRODUCT AVAILABILITY ISSUE 1 0.0000
311 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
312 COGNITIVE DISORDER 2 0.0000
313 TREMOR 7 0.0000
314 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
315 HAEMATEMESIS 1 0.0000
316 DRUG RESISTANCE 1 0.0000
317 INFLAMMATION 2 0.0000
318 MUCOSAL INFLAMMATION 1 0.0000
319 ANHEDONIA 1 0.0000
320 FREQUENT BOWEL MOVEMENTS 1 0.0000
321 MOOD ALTERED 1 0.0000
322 SKIN LESION 1 0.0000
323 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
324 WOUND 1 0.0000
325 PAIN IN JAW 1 0.0000
326 FLATULENCE 2 0.0000
327 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
328 HEPATIC FAILURE 1 0.0000
329 FEELING HOT 2 0.0000
330 FEMUR FRACTURE 1 0.0000
331 ASTHENIA 12 0.0000
332 MOOD SWINGS 1 0.0000
333 CONTUSION 3 0.0000
334 PAIN 19 0.0000
335 IMPAIRED HEALING 1 0.0000
336 DEATH 26 0.0000
337 EXPIRED PRODUCT ADMINISTERED 1 0.0000
338 ABDOMINAL PAIN UPPER 6 0.0000
339 GASTRIC DISORDER 1 0.0000
340 RASH MACULAR 1 0.0000
341 CEREBRAL HAEMORRHAGE 1 0.0000
342 THROMBOCYTOPENIA 3 0.0000
343 EPISTAXIS 2 0.0000
344 PYREXIA 9 0.0000
345 ABNORMAL BEHAVIOUR 1 0.0000
346 DISORIENTATION 1 0.0000
347 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
348 BLINDNESS 1 0.0000
349 POLLAKIURIA 1 0.0000
350 RENAL FAILURE ACUTE 1 0.0000
351 HYPOACUSIS 1 0.0000
352 PULMONARY OEDEMA 1 0.0000
353 MEMORY IMPAIRMENT 3 0.0000
354 SKIN IRRITATION 1 0.0000
355 ARRHYTHMIA 1 0.0000
356 COMA 1 0.0000
357 ATRIAL FIBRILLATION 2 0.0000
358 DRY EYE 1 0.0000
359 HEADACHE 12 0.0000
360 HAEMATOCHEZIA 1 0.0000
361 FATIGUE 14 0.0000
362 OXYGEN SATURATION DECREASED 1 0.0000
363 DEPRESSION 4 0.0000
364 SURGERY 1 0.0000
365 CATARACT 1 0.0000
366 ILL-DEFINED DISORDER 1 0.0000
367 VERTIGO 1 0.0000
368 EXPOSURE DURING PREGNANCY 1 0.0000
369 BLOOD GLUCOSE INCREASED 3 0.0000
370 INJECTION SITE REACTION 1 0.0000
371 COUGH 4 0.0000
372 THERAPY INTERRUPTED 1 0.0000
373 RESPIRATORY FAILURE 1 0.0000
374 AGITATION 1 0.0000
375 DYSGEUSIA 1 0.0000
376 CHRONIC KIDNEY DISEASE 1 0.0000
377 ACUTE KIDNEY INJURY 2 0.0000
378 PARAESTHESIA 2 0.0000
379 DRUG ABUSE 1 0.0000
380 RENAL IMPAIRMENT 1 0.0000
381 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
382 ADVERSE EVENT 1 0.0000
383 HEART RATE INCREASED 1 0.0000
384 ERYTHEMA 2 0.0000
385 PLATELET COUNT DECREASED 1 0.0000
386 INFLUENZA 1 0.0000
387 INCORRECT DOSE ADMINISTERED 2 0.0000
388 EMOTIONAL DISTRESS 1 0.0000
389 DIARRHOEA 5 0.0000
390 RENAL FAILURE 1 0.0000
391 INSOMNIA 2 0.0000
392 INFECTION 1 0.0000
393 PERIPHERAL SWELLING 1 0.0000
394 CONFUSIONAL STATE 1 0.0000
395 ABDOMINAL DISCOMFORT 1 0.0000
396 TOXICITY TO VARIOUS AGENTS 1 0.0000
397 MUSCLE SPASMS 1 0.0000
398 HYPERSENSITIVITY 1 0.0000
399 GAIT DISTURBANCE 1 0.0000
400 PRURITUS 2 0.0000
401 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
402 RASH 2 0.0000
403 WEIGHT INCREASED 1 0.0000
404 DECREASED APPETITE 1 0.0000
405 FEELING ABNORMAL 1 0.0000
406 DIZZINESS 2 0.0000
407 WEIGHT DECREASED 1 0.0000
408 PAIN IN EXTREMITY 1 0.0000